{
  "Products": "Dynamic Biotechnology & Genome ETF",
  "Ticker": "PBE",
  "Inception": "06/23/2005",
  "Gross Exp. Ratio": "0.57%",
  "YTD": "1.30",
  "1Yr": "19.46",
  "3Yr": "4.29",
  "5Yr": "4.68",
  "10Yr": "11.61",
  "Since Incept.": "9.46",
  "Category": "Multi Factor",
  "SubCategory": "Intellidex Industries",
  "ticker": "PBE",
  "issuer": "Invesco",
  "website": "https://www.invesco.com/us/financial-products/etfs/product-detail?audienceType=Investor&ticker=PBE",
  "holdingDataSource": {
    "url": "https://www.invesco.com/us/financial-products/etfs/holdings/main/holdings/0?audienceType=Investor&action=download&ticker=PBE",
    "fileExt": "csv",
    "transform": "invesco"
  },
  "holdings": [
    {
      "ticker": "PACB",
      "name": "Pacific Biosciences of California Inc",
      "percent": "5.838"
    },
    {
      "ticker": "QGEN",
      "name": "QIAGEN NV",
      "percent": "4.896"
    },
    {
      "ticker": "BIIB",
      "name": "Biogen Inc",
      "percent": "4.720"
    },
    {
      "ticker": "REGN",
      "name": "Regeneron Pharmaceuticals Inc",
      "percent": "4.590"
    },
    {
      "ticker": "GILD",
      "name": "Gilead Sciences Inc",
      "percent": "4.452"
    },
    {
      "ticker": "AMGN",
      "name": "Amgen Inc",
      "percent": "4.389"
    },
    {
      "ticker": "ILMN",
      "name": "Illumina Inc",
      "percent": "4.375"
    },
    {
      "ticker": "NBIX",
      "name": "Neurocrine Biosciences Inc",
      "percent": "4.226"
    },
    {
      "ticker": "CDNA",
      "name": "CareDx Inc",
      "percent": "3.879"
    },
    {
      "ticker": "VRTX",
      "name": "Vertex Pharmaceuticals Inc",
      "percent": "3.742"
    },
    {
      "ticker": "FATE",
      "name": "Fate Therapeutics Inc",
      "percent": "3.604"
    },
    {
      "ticker": "INSM",
      "name": "Insmed Inc",
      "percent": "3.379"
    },
    {
      "ticker": "OPK",
      "name": "OPKO Health Inc",
      "percent": "3.332"
    },
    {
      "ticker": "NTLA",
      "name": "Intellia Therapeutics Inc",
      "percent": "3.275"
    },
    {
      "ticker": "XLRN",
      "name": "Acceleron Pharma Inc",
      "percent": "3.167"
    },
    {
      "ticker": "CRSP",
      "name": "CRISPR Therapeutics AG",
      "percent": "3.154"
    },
    {
      "ticker": "FOLD",
      "name": "Amicus Therapeutics Inc",
      "percent": "3.070"
    },
    {
      "ticker": "DRNA",
      "name": "Dicerna Pharmaceuticals Inc",
      "percent": "2.905"
    },
    {
      "ticker": "FGEN",
      "name": "FibroGen Inc",
      "percent": "2.825"
    },
    {
      "ticker": "UTHR",
      "name": "United Therapeutics Corp",
      "percent": "2.794"
    },
    {
      "ticker": "EXEL",
      "name": "Exelixis Inc",
      "percent": "2.740"
    },
    {
      "ticker": "ALKS",
      "name": "Alkermes PLC",
      "percent": "2.717"
    },
    {
      "ticker": "HALO",
      "name": "Halozyme Therapeutics Inc",
      "percent": "2.656"
    },
    {
      "ticker": "SGMO",
      "name": "Sangamo Therapeutics Inc",
      "percent": "2.651"
    },
    {
      "ticker": "IRWD",
      "name": "Ironwood Pharmaceuticals Inc",
      "percent": "2.608"
    },
    {
      "ticker": "CHRS",
      "name": "Coherus Biosciences Inc",
      "percent": "2.457"
    },
    {
      "ticker": "NKTR",
      "name": "Nektar Therapeutics",
      "percent": "2.296"
    },
    {
      "ticker": "EBS",
      "name": "Emergent BioSolutions Inc",
      "percent": "2.145"
    },
    {
      "ticker": "FLDM",
      "name": "Fluidigm Corp",
      "percent": "2.063"
    },
    {
      "ticker": "AKBA",
      "name": "Akebia Therapeutics Inc",
      "percent": "0.953"
    },
    {
      "ticker": "AGPXX",
      "name": "STIT - Government & Agency Portfolio",
      "percent": "0.105"
    }
  ]
}